Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.

Research output: Contribution to journalPublished meeting abstract

Bibtex

@article{d82ab9cb2c82482badf293ef72567e1e,
title = "Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.",
author = "MM Tanner and JJ Isola and T Wiklund and B Erikstein and P Kellokumpu-Lehtinen and Per Malmstr{\"o}m and N Wilking and J Nilsson and J Bergh",
year = "2005",
language = "English",
volume = "23",
pages = "841S--841S",
journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
issn = "1527-7755",
publisher = "American Society of Clinical Oncology",
number = "16S",

}